Skip to content
Search AI Powered

Latest Stories

Over 50% of pharmacists with disabilities face workplace discrimination

Over 50% of pharmacists with disabilities face workplace discrimination

‘Employers should create an environment where pharmacists with disabilitiescan work safely and without fear of discrimination’

The Pharmacists' Defence Association Ability Network or PDA Ability Network has released initial findings from its disability discrimination survey, indicating the need for significant efforts to make workplaces more inclusive for pharmacists with disabilities.

Launched in February this year, the survey aims to establish the extent of discrimination faced in the workplace by pharmacists who are disabled or live with a long-term health condition.


Respondents reported encountering disability discrimination in a variety of ways, from employment being withdrawn upon discovery of their disability to employers declining to offer reasonable adjustments.

The initial survey report revealed that 40 per cent of participants expressed feeling excluded from the workforce, underemployed, or unemployed because of their disability.

It was found that nearly 70 per cent of participants either did not receive reasonable adjustments or only received partial reasonable adjustments to accommodate their disability.

More than half of respondents (53 per cent) reported experiencing discrimination in the workplace.

Among those who faced discrimination, 60 per cent said it came from their manager, while 40 per cent reported experiencing discrimination from colleagues.

Liz Larkin, PDA organiser and co-ordinator for the PDA Ability Network, said “Pharmacists are a talented skilled workforce but a proportion of pharmacists who have disabilities or long-term health conditions are discriminated against and excluded from the workforce.

“This is a terrible loss of skills and talent and we need employers to create an environment where disabled members can work safely and without fear of discrimination.”

The network said that it will use this evidence to inform its next campaign to lobby employers to meet their obligations under the Equality Act 2010 to provide reasonable adjustments.

“With one in five people in the UK being disabled, discrimination not only causes real distress, it means that a valued group of the workforce may find themselves not working should their employer not support them,” the network noted.

PDA members are encouraged to complete the online survey by Tuesday 30 April 2024.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less